Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Mayengue, Pembe ^a,b   Ndounga, Mathieu ^c   Malonga, Freddy ^a,b   Bitemo, Michel ^d   Ntoumi, Francine ^a,b,e  

^a Fondation Congolaise Pour la Recherche Medicale   (Congo)

^b UNIVERSITÉ MARIEN NGOUABI   (Congo)

^c Centre d'Etudes sur les Ressources Végétales   (Congo)

^d Centre de Recherche et d'Etude en Sciences Sociales et Humaines   (Congo)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; MEROZOITE SURFACE PROTEIN 2, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOAL PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CHILD; CONGO; DNA EXTRACTION; DRUG SCREENING; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEALTH CENTER; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MULTIGENE FAMILY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SCHOOL CHILD; GENETICS; ISOLATION AND PURIFICATION; MALARIA FALCIPARUM; METHODOLOGY; MIDDLE AGED; PARASITOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CONGO; DNA, PROTOZOAN; FEMALE; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; YOUNG ADULT;

EID: 80053172189     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-276     Document Type: Article

References (32)

1. WHO, World malaria report 2010 http://www.who.int/malaria/world-malaria- report-2010
2. Malaria vaccine development: an endemic country perspective. Koram KA, Gyan BA, Hum Vaccin 2010 6 12 16 10.4161/hv.6.1.9605 19806020
3. [Nighttime attendance at the Pediatric Emergency Room of the University Hospital Centre in Brazzaville, Congo](in French). Mabiala-Babela JR, Senga P, Med Trop 2009 69 281 285
4. Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Nsimba B, Malonga DA, Mouata AM, Louya F, Kiori J, Malanda M, Yocka D, Oko-Ossho J, Ebata-Mongo S, Le Bras J, Am J Trop Med Hyg 2004 70 133 138 14993623 (Pubitemid 38200516)
5. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Congo. Mayengue PI, Ndounga M, Davy MM, Tandou N, Ntoumi F, Acta Trop 2005 95 219 225 10.1016/j.actatropica.2005.06.001 16002038 (Pubitemid 41207285)
6. Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo). Ndounga M, Mayengue PI, Tahar R, Casimiro PN, Matondo Maya DW, Miakassissa-Mpassi V, Malonga DA, Nsonde-Ntandou F, Mallanda G, Ringwald P, Basco LK, Ntoumi F, Acta Trop 2007 103 163 171 10.1016/j.actatropica.2007.06.002 17645863 (Pubitemid 47307325)
7. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP, J Infect Dis 2002 185 820 8207 10.1086/339342 11920300 (Pubitemid 34226210)
8. Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. al-Yaman F, Genton B, Reeder JC, Anders RF, Smith T, Alpers MP, Trans R Soc Trop Med Hyg 1997 91 602 605 10.1016/S0035-9203(97)90046-8 9463681 (Pubitemid 27478660)
9. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. Farnert A, Rooth I, Snounou G, Bjorkman A, J Infect Dis 1999 179 989 995 10.1086/314652 10068596 (Pubitemid 29159346)
10. Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population. Bereczky S, Liljander A, Rooth I, Faraja L, Granath F, Montgomery SM, Farnert A, Microbes Infect 2007 9 103 110 10.1016/j.micinf.2006.10.014 17194613 (Pubitemid 46149423)
11. The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Mayengue PI, Luty AJ, Rogier C, Baragatti M, Kremsner PG, Ntoumi F, Microbes Infect 2009 11 108 114 10.1016/j.micinf.2008.10.012 19028595
12. Plasmodium falciparum merozoite surface protein 1 (MSP-1): genotyping and humoral responses to allele-specific variants. Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F, Acta Trop 2002 81 33 46 10.1016/S0001-706X(01)00188-7 11755430 (Pubitemid 34033711)
13. Site-based study on polymorphism of Plasmodium falciparum msp-1 and msp-2 genes in isolates from two villages in Central Africa. Ntoumi F, Ngoundou-Landji J, Lekoulou F, Luty A, Deloron P, Ringwald P, Parassitologia 2000 42 197 203 11686079
14. Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients. Basco LK, Tahar R, Escalante A, Am J Trop Med Hyg 2004 70 238 244 15031510 (Pubitemid 38366525)
15. Genetic diversity of Plasmodium falciparum in Bolifamba, on the slopes of Mount Cameroon: influence of msp1 allelic variants on symptomatic malaria and anaemia. Anong DN, Nkuo-Akenji T, Fru-Cho J, Amambua-Ngwa A, Titanji VP, Ann Trop Med Parasitol 2010 104 25 33 10.1179/136485910X12607012373876 20149290
16. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use. Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Bras J, Trop Med Int Health 2005 10 1030 1037 10.1111/j.1365-3156.2005.01490.x 16185238 (Pubitemid 41445068)
17. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo. Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F, Trop Med Int Health 2007 12 1164 1171 10.1111/j.1365-3156.2007.01904.x 17956498 (Pubitemid 47621998)
18. Criteria for diagnosing clinical malaria among a semi-immune population exposed to intense and perennial transmission. Trape JF, Peelman P, Morault-Peelman B, Trans R Soc Trop Med Hyg 1985 79 435 442 10.1016/0035- 9203(85)90054-9 3909550
19. Malaria and urbanization in central Africa: the example of Brazzaville. Part V: Pernicious attacks and mortality. Trape JF, Quinet MC, Nzingoula S, Senga P, Tchichelle F, Carme B, Candito D, Mayanda H, Zoulani A, Trans R Soc Trop Med Hyg 1987 81 Suppl 2 34 42 3455565 (Pubitemid 18056970)
20. Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Culleton RL, Mita T, Ndounga M, Unger H, Cravo PV, Paganotti GM, Takahashi N, Kaneko A, Eto H, Tinto H, Karema C, D'Alessandro U, do Rosario V, Kobayakawa T, Ntoumi F, Carter R, Tanabe K, Malar J 2008 7 174 10.1186/1475-2875-7-174 18783630
21. Transmission-dependent tolerance to multiclonalPlasmodium falciparum infection. Farnert A, Williams TN, Mwangi TW, Ehlin A, Fegan G, Macharia A, Lowe BS, Montgomery SM, Marsh K, J Infect Dis 2009 200 1166 1175 10.1086/605652 19702508
22. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Kun JF, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner D, Greve B, Matousek P, Kremsner PG, Trans R Soc Trop Med Hyg 1998 92 110 114 10.1016/S0035-9203(98)90979-8 9692171 (Pubitemid 28073749)
23. Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon. Aubouy A, Migot-Nabias F, Deloron P, Malar J 2003 2 12 10.1186/1475-2875-2-12 12773207
24. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, Trape JF, Mercereau-Puijalon O, Am J Trop Med Hyg 1998 59 726 735 9840589 (Pubitemid 28524529)
25. Plasmodium falciparum: a comparative analysis of the genetic diversity in malaria-mesoendemic areas of Brazil and Madagascar. Sallenave-Sales S, Daubersies P, Mercereau-Puijalon O, Rahimalala L, Contamin H, Druilhe P, Daniel-Ribeiro CT, Ferreira-da-Cruz MF, Parasitol Res 2000 86 692 698 10.1007/PL00008554 10952272
26. Genetic diversity in merozoite surface protein (msp-1 and msp-2) genes of Plasmodium falciparum in a major endemic region of Iran. Heidari A, Keshavarz H, Rokni MB, Jelinek T, Korean J Parasitol 2007 45 59 63 10.3347/kjp.2007.45.1. 59 17374980
27. Genetic diversity of Plasmodium falciparum and its relationship to parasite density in an area with different malaria endemicities in West Uganda. Peyerl-Hoffmann G, Jelinek T, Kilian A, Kabagambe G, Metzger WG, von Sonnenburg F, Trop Med Int Health 2001 6 607 613 10.1046/j.1365-3156.2001.00761.x 11555426 (Pubitemid 32830480)
28. Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients. Basco LK, Ringwald P, Am J Trop Med Hyg 2001 65 798 803 11791977 (Pubitemid 34049475)
29. Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals living in Bangui (CAR). Dolmazon V, Matsika-Claquin MD, Manirakiza A, Yapou F, Nambot M, Menard D, Acta Trop 2008 107 37 42 10.1016/j.actatropica.2008.04.012 18501320
30. Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Contamin H, Fandeur T, Rogier C, Bonnefoy S, Konate L, Trape JF, Mercereau-Puijalon O, Am J Trop Med Hyg 1996 54 632 643 8686784 (Pubitemid 26238836)
31. Plasmodium falciparum multiple infections in Mozambique, its relation to other malariological indices and to prospective risk of malaria morbidity. Mayor A, Saute F, Aponte JJ, Almeda J, Gomez-Olive FX, Dgedge M, Alonso PL, Trop Med Int Health 2003 8 3 11 10.1046/j.1365-3156.2003.00968.x 12535242 (Pubitemid 36151570)
32. A cohort study of Plasmodium falciparum diversity during the dry season in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Zwetyenga J, Rogier C, Spiegel A, Fontenille D, Trape JF, Mercereau-Puijalon O, Trans R Soc Trop Med Hyg 1999 93 375 380 10.1016/S0035-9203(99)90122-0 10674080 (Pubitemid 29405861)